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Abstract
Longitudinal mouse PET imaging is becoming increasingly popular due to the large number of transgenic and disease models
available but faces challenges. These challenges are related to the small size of the mouse brain and the limited spatial resolution
of microPET scanners, along with the small blood volume making arterial blood sampling challenging and impossible for
longitudinal studies. The ability to extract an input function directly from the image would be useful for quantification in
longitudinal small animal studies where there is no true reference region available such as TSPO imaging.
Methods Using dynamic, whole-body 18F-DPA-714 PETscans (60 min) in a mouse model of hippocampal sclerosis, we applied
a factor analysis (FA) approach to extract an image-derived input function (IDIF). This mouse-specific IDIF was then used for
4D-resolution recovery and denoising (4D-RRD) that outputs a dynamic image with better spatial resolution and noise properties,
and a map of the total volume of distribution (VT) was obtained using a basis function approach in a total of 9 mice with 4
longitudinal PET scans each. We also calculated percent injected dose (%ID) with and without 4D-RRD. The VT and %ID
parameters were compared to quantified ex vivo autoradiography using regional correlations of the specific binding from
autoradiography against VT and %ID parameters.
Results The peaks of the IDIFs were strongly correlated with the injected dose (Pearson R = 0.79). The regional correlations
between the %ID estimates and autoradiography wereR = 0.53without 4D-RRD and 0.72with 4D-RRD over all mice and scans.
The regional correlations between the VT estimates and autoradiography were R = 0.66 without 4D-RRD and 0.79 with appli-
cation of 4D-RRD over all mice and scans.
Conclusion We present a FA approach for IDIF extraction which is robust, reproducible and can be used in quantification
methods for resolution recovery, denoising and parameter estimation. We demonstrated that the proposed quantification method
yields parameter estimates closer to ex vivo measurements than semi-quantitative methods such as %ID and is immune to tracer
binding in tissue unlike reference tissue methods. This approach allows for accurate quantification in longitudinal PET studies in
mice while avoiding repeated blood sampling.
Keywords PET . TSPO . Factor analysis . Mouse . Image-derived input function
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Background
Dedicated PET machines enable mouse imaging with the
large number of transgenic mice and disease models available
[1]. In longitudinal PET studies, the changes in receptor or
protein expression can be small, which means that sophisti-
cated quantification and physiological parameter estimation
methods would be needed to identify such small variations.
The gold standard parameter estimation method is to use com-
partmental analysis with a metabolite-corrected plasma curve
from arterial blood sampling [2]. However, blood sampling
throughout a mouse PET scan is extremely difficult and im-
possible in a longitudinal study due to the limited blood vol-
ume of the mouse.
For some targets, there is the possibility to use a reference
region for compartmental modelling to estimate binding pa-
rameters. This is not the case for targets where there is no brain
region without the target present, such as the translocator pro-
tein (TSPO). TSPO has been demonstrated as a biomarker in
diseases that have a component of neuroinflammation such as
epilepsy and Alzheimer’s disease. Among the most common-
ly used TSPO tracers, 18F-DPA-714 was recently shown to be
able to follow TSPO expression longitudinally in a mouse
model of epilepsy with hippocampal sclerosis [3, 4]. Due to
the low-level basal expression of TSPO in healthy brain tissue,
and because the pattern of over-expression is unknown in
some disease states, using a reference region is suboptimal.
Additionally, the small size of the mouse brain com-
pared to the limited spatial resolution of the PET scanner
induces significant partial volume effects between brain
structures that need to be corrected for accurate activity
quantification and subsequent parameter estimation in
brain studies [5, 6].
Current methods of quantification for mouse TSPO PET
studies have been relatively simple and include measure-
ments of standardized uptake values (SUV) or percent
injected dose per cc (%ID) [3, 4]. For some studies where
the longitudinal pattern of pathology is known, an anatom-
ical pseudo-reference region was used [7, 8]. Another
group performed a normalization against a manually
defined region of interest (ROI) over cardiac tissue [9].
Most studies do not apply any partial volume effect
(PVE) correction to the images further complicating the
detection of group differences [5, 6].
We propose a generic method for quantification of TSPO
PETscans in the mouse by taking the focus away from finding
an appropriate reference or pseudo-reference region and using
a data-driven approach instead, to extract a blood input func-
tion from the whole-body image of the mouse.
To obtain an image-derived input function (IDIF) for
mouse scans, a common method is to define a ROI over
the aorta or a blood pool in the heart [10, 11]. This is not
always ideal due to the limited spatial resolution producing
strong PVE in the small vessel and cardiac structures,
resulting in a highly contaminated blood curve. To over-
come these limitations, one group tested a PVE correction
that uses anatomical information from an MRI [12]. Yet,
for TSPO tracers, this method will not give an adequate
blood curve due to the high level of TSPO expression in
the heart [13] and blood vessels [14]. To avoid the need for
manual VOI placement or precise image registration tech-
niques, we investigated factor analysis (FA) for estimating
the blood curve and estimating the TSPO-tracer binding
signal.
FA approaches have already been used in PET imaging, for
noise removal [15], for the separation of biological signals
[16–20] and also for IDIF extraction in canines [21], humans
[22, 23] and in the mouse [24]. However, using FA to derive
an accurate IDIF for binding parameter estimation in mouse
studies has not yet been reported.
In this study, we present and evaluate a FA approach for
extracting a robust IDIF from mouse 18F-DPA-714 PET
scans for biological parameter estimation in the brain.
This IDIF was used in a 4D-resolution recovery and noise
reduction algorithm (4D-RRD) which performs iterative
deconvolution combined with a basis function noise re-
moval and enables subsequent parameter estimation [5, 6,
25]. The 4D-RRD process results in an image with higher
spatial resolution and better noise properties than the orig-
inal and produces a parametric map of the total volume of
distribution (VT). The VT maps were compared to quanti-
tative ex vivo autoradiography using the structural ana-
logue 3H-DPA-714. We also calculated the %ID for each
scan, a commonly used semi-quantitative measure for
comparison to the VT and autoradiography to highlight
the importance of using accurate and robust quantification
methods.
Methods
Animal models
All experiments involving animals were conducted according
to the European directive 2010/63/EU and its transposition in
the French law (Décret n° 2013-118). Animal experiments
were conducted at the imaging facility CEA-SHFJ (authoriza-
tion D91-471-105/ethic committee n°44).
Experiments were performed on adult C57/BL6 male mice
(4 months old) (Charles River, France) housed in individual
cages. The mouse model of epilepsy was induced as previous-
ly described. Briefly, an injection of kainic acid (KA) was
made into the right dorsal hippocampus [26, 27] of 21 mice
(n = 9 for longitudinal PET imaging, n = 12 for ex vivo
autoradiography).
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PET and MR imaging
Each mouse underwent 18F-DPA-714 scans before KA induc-
tion (baseline, n = 9) and after the KA induction at 7 days (n =
6), 1 month (n = 8) and 6 months (n = 8). Longitudinal scans
were performed on the same animals whenever possible.
Table 1 shows at which time point each mouse was scanned.
18F-DPA-714 was synthesized as previously described
[28]. Mice were anesthetised with isoflurane (3.5% for in-
duction, 1.5–2% for maintenance). Dynamic PET scans of
60 min (framing 3 × 30 seconds (s), 5 × 60 s, 5 × 120 s, 3 ×
180 s, 3 × 240 s, 4 × 300 s, 1 × 240 s) were acquired with a
tail vein injection (1 min using an injection pump) of 5.3 ±
1.6 MBq of 18F-DPA-714 (injected mass, 0.097 ±
0.04 nmol; specific activity, 66 ± 39 GBq/μmol; volume,
100 μl) using the Inveon microPET-CT (Siemens Medical
Solutions, Knoxville, TN, USA). An additional cohort of
healthy animals was used for a presaturation study (n = 6).
These animals were given a large dose of non-radioactive
DPA-714 before the radioactive tracer administration to
saturate the TSPO binding (hot dose 0.33 ± 0.3 nmol, sta-
ble compound 64 ± 0.0 nmol). After the PET scan, a 6 min
80 kV/500 μA CT scan was performed for attenuation cor-
rection and for registering PET/CT images to an MRI tem-
plate. Animals were scanned at the 6-month time point on
an 11.7 T MRI scanner equipped with a CryoProbe dedi-
cated for mouse brain imaging (Bruker BioSpin, Ettlingen,
Germany) in order to acquire anatomical T2*-weighted
MRI (Multi-gradient-echo sequence, TR = 100 ms, weight-
ed average of 8 echo-images with TE ranging from 2.5 to
23.5 ms, resolution 80 × 80 × 160 μm) and assess morpho-
logical changes in the hippocampus and surrounding struc-
tures. Individual MRI was manually registered to an MRI
atlas template [29].
Table 1 Outline of which mice had scans at which time point
Time point: Baseline 7 days 1 month 6 months
Mouse 1 0 30 183
Mouse 2 0 30 184
Mouse 3 0 30 184
Mouse 4 0 7 28 169
Mouse 5 0 7 35 243
Mouse 6 0 7 29 236
Mouse 7 0 7 28
Mouse 8 0 7 28 226
Mouse 9 0 7 197
The filled black table entry indicates that the mouse was scanned at that time point, and a white entry indicates the mouse did not undergo a scan. The
number within each box is the number of days since KA induction
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Image reconstruction
PET Images were reconstructed using a 2D OSEM iterative
algorithm (4 iterations, 16 subsets, voxel size = 0.4 mm ×
0.4 mm× 0.8 mm). Normalization, dead time correction, ran-
doms subtraction, CT-based attenuation and scatter correc-
tions were applied. In order to create average PET parametric
maps for each of the time points, the PET scans were regis-
tered into the same space using the CT scans, which are ac-
quired in the same reference space. The CT scans were
cropped around the skull, and one baseline CT scan was cho-
sen as reference which each of the others were registered to.
For ROI definition of regions of interest, the reference CTwas
manually registered to an MRI atlas [29]. The transformation
matrices between the PET, CT and MRI atlas were combined
to position the ROI in the PET image volume.
Autoradiography
The autoradiography was performed on four cohorts of mice
(baseline, n = 3; 7 days, n = 3; 1 month, n = 3; and 6 months,
n = 3) as described in Nguyen et al. [4]. The density of TSPO
binding sites was measured by in vitro autoradiographic ex-
periments using [3H]DPA714 (Specific Activity 2.01 GBq/
μmol provided by F. Dollé, CEA, Institut des Sciences du
Vivant Frédéric Joliot, SHFJ, Université Paris-Saclay, Orsay,
France) according to the method used in Foucault-Fruchard
et al. [30]. Non-specific binding was assessed in the presence
of 1 μmol/L PK-11195 (Sigma-Aldrich, Saint-Quentin-
Fallavier, France). 3H autoradiography was used because it
provides better resolution and hence more accurate quantifi-
cation compared to 18F [31].
For quantification, four sections were analysed per mouse.
ROIs were manually drawn on seven regions (left and right
hippocampus, cortex, thalamus and whole cerebellum) using
the Paxinos atlas as reference [32]. These ROIs are presented
in Supplementary Fig. 3. Using the β-vision software
(Biospace Lab), the level of bound radioactivity was directly
determined by counting the β-particles emitted from the de-
lineated area. The radioligand signal in the ROIs was mea-
sured for each mouse and expressed as counts per minute per
square millimetre (cpm/mm2). Specific binding was deter-
mined by subtracting non-specific binding (as described
above) from total binding.
Image-derived input function using factor analysis
FA was performed using PIXIES software (http://www.
apteryx.fr/) on the original reconstructed dynamic scans. FA
of medical images has been shown to effectively separate
biological signals and remove noise [16–22, 33]. The FA
model assumes that the dynamic image is made up of a
limited number of fundamental spatial distributions which
may or may not be overlapping, each one corresponding to a
specific biological signal. The signal in each voxel from the
original image over time (Si(t)) is expressed as a linear
combination of factor curves (fk(t)) plus the error term
(incorporating the noise and any modelling errors, ei(t)) [19]:
Si tð Þ ¼ ∑Kk¼1ak ið Þ f k tð Þ þ ei tð Þ:
The weights ak(i) correspond to the portion of signal Si(t)
that follows the fk time curve so that the ak image reflects the
spatial distribution of signal with the fk kinetics.
The FA model was solved in 2 steps. First, a principal
component analysis (PCA) was performed, and the three 1st
principal components were used to span the PCA space. The
signal Si(t) in each voxel i was projected into that space, and a
K-means algorithm was used to identify 4 clusters in that
space. The centroids of these 4 clusters were used as initial
factors fk(t). The identification of the final factors relies on a
number of constraints reflecting priors [34]. We used the fol-
lowing constraints (Fig. 1) for all scans:
P1. All factors and images should be positive.
P2. One factor should have one maximum only with its
maximum in the frame corresponding to 30–60 s.
Among the 4 factors, the one that best met P2 constraint
was automatically identified as the IDIF factor. Then the fac-
tors were iteratively refined to meet P1 and P2 using the algo-
rithm described in Benali et al. [34], with P2 applied to the
previously identified IDIF factor. To force P2, the IDIF factor
curve was altered when needed so as to have its maximum in
the 30–60 s frame, to be increasing before that max and to be
decreasing after, and the resulting curve was projected in the
PCA space. The iterative process was automatically stopped
when the factors did not change substantially between two
successive iterations.
The factor curves were normalized to the activity within the
scan (Bq) as shown in Fig. 1. The IDIF was then converted to
%ID, and the mean and standard deviation over all curves
obtained from all mice and all longitudinal PET scans in a
given mouse were calculated.
IDIF calculation: presaturation and tracer dose studies
TSPO present in the heart, lung, vascular tissue and in the
blood can confound the estimation of the IDIF in tracer dose
studies. When the TSPO is blocked with cold ligand in the
presaturation experiments, the confounding binding compo-
nent is removed from the total signal. For the presaturation
scans, 3 factors were thus extracted, and priors P1 and P2 as
above were used.
IDIF estimation from tracer dose scans was performed with
one extra factor to account for the binding of the ligand and
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Fig. 1 Process for extracting the IDIF from the dynamic PETscan: (1) the
whole-body dynamic PET captures all activity; (2) FA is run with 3
(presaturation) or 4 (tracer dose) factors – the factor curves are shown
along with their corresponding spatial distribution and relative intensity.
The curve with the earliest peak (in red) shows the strongest signal in the
expected regions for blood (tail vein, aorta, lungs); (3) all factors are
summed together; (4) the whole-body TAC is obtained from a ROI placed
around the whole body, and the total activity in Bq is calculated from the
measured activity concentration (Bq/cc) multiplied by ROI volume; (5)
the ratio between the summed factors and the whole-body TAC is calcu-
lated and the average of the ratio from 10 min onwards is calculated; (6)
the blood factor curve is normalized to Bq using the average ratio value.
This IDIF is then metabolite corrected and used in the image processing
and parameter estimation
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one extra constraint: P3. The shape of one factor should be
similar to the average IDIF obtained from all 6 presaturation
experiments.
The extracted IDIFs were metabolite corrected using a pop-
ulation metabolite curve (Supplementary Fig. 1) [35] and
fitted using a previously described method [36].
Image processing for spatial resolution recovery
and noise removal
For spatial resolution recovery and noise removal, a 4D itera-
tive deconvolution process is performed with a basis pursuit
denoising for temporal regularization (4D-RRD) implemented
in GNU Octave [5, 6, 37]. This method used a set of 12 basis
functions generated by convolving an input function with a set
of exponentials to fit the time-activity curve (TAC) from each
voxel [25]. The input function used to generate the basis func-
tions was the IDIF extracted from each individual animal
which had been metabolite corrected. The output of 4D-
RDD is a dynamic image that has higher spatial resolution
and reduced noise compared to the original and a parametric
map of the distribution volume, VT, which is estimated using
the basis pursuit method as described in Gunn et al. 2002 [25].
For this study, the number of iterations used was 0, 10 and 15
iterations so that the results after each step of the image pro-
cessing could be analysed. Zero iteration corresponds to the
application of the denoising and VT estimation only, with no
partial volume correction.
Parameters estimated
The parametric maps of VT at 0, 10 and 15 iterations of 4D-
RRD were used to calculate regional VT values. The VT
values were calculated using the basis pursuit method (Gunn
et al. 2005) which is integrated into the 4D-RDD resolution
recovery and noise reduction method as described above [6].
The basis pursuit method of parameter estimation is particu-
larly robust against noise and hence well suited for generating
voxel-wise maps. The %ID was also calculated from the orig-
inal images (without 4D-RDD) and from the images produced
with 10 iterations of 4D-RRD. Regional values of VT
and %ID were extracted from the parametric images using
the registered mouse brain atlas.
Comparison of quantification method
to autoradiography
The specific binding values were obtained from the autoradi-
ography for the regions as described above. Regional group
averages for the PET measures of %ID or VTwere correlated
against the measured activity from the autoradiography slices
for all animals at the different time points for 7 regions of
interest (left and right cortex, hippocampus, thalamus and
whole cerebellum). The autoradiography measurement repre-
sents only the specific binding of the tracer, whereas the VT
estimate represents the non-displaceable tracer (VND which
incorporates the free tracer in tissue, VF, plus the non-
specific binding, VNS) and the specific binding (VS). Ideally,
VT should have a direct relationship with specific binding, but
may not, due to non-specific binding or differences in the free
tracer in tissue.
Results
Factor analysis
Figure 1 (2) shows the four different factors identified in the
mouse PET image of the tracer studies. The image beside each
of the 4 identified factors in the corresponding colour shows
the spatial distribution of the factor which can help to interpret
the biological meaning of each curve. There is strong presence
of the factor with the earliest peak (red) within the lungs, and
the signal is very high in the abdominal artery/vein compared
to the other factors, indicating that it is mainly coming from
blood. There is little signal seen in the ventricles (not shown)
for the blood factor, which could be due to the heart motion
causing the signal to be more diluted than it is in the aorta. The
factor that peaks second (green) appears in the lungs, kidneys
and abdominal region could be related to free tracer in tissue,
with a large proportion appearing in the lungs, which are
highly perfused. The third factor in blue could describes the
specific binding of the tracer, with high concentration in the
kidneys and lungs, where it is known that there is high TSPO
density, including in the mouse as shown in [13]. The factor in
yellow shows a shape related to the accumulation of tracer and
is strongest in the kidneys, which could therefore be related to
excretion. There is very little of this signal seen in the lungs or
the rest of the body.
IDIF obtained using factor analysis
The left panel of Fig. 2a shows the average IDIF extracted
from the presaturation experiments, with the curve fit and a
plot of the residuals. The right panel (b) is the average IDIFs
extracted for tracer experiments at each of the time points,
which show the small difference between peak values (not
significant). Peak magnitude of the IDIF correlates very well
with the injected dose (all, Pearson R = 0.79; baseline, R =
0.93; 7 days, R = 0.95; 1 month, R = 0.80; and 6 months,
R = 0.66 (0.84 excluding one outlier)).
Parameter estimates
The plots in Fig. 3 show that the regional pattern of the VT is
similar to that of the autoradiography in comparison to the
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%ID which has a much flatter regional distribution. The sim-
ilarity between the VT values and autoradiography is strong
within the cortex and the cerebellum, where the %ID is more
variable over the 4 time points, showing an increase at 7 days
and 6 months for all regions. There is a discrepancy between
the peak at 7 days in the hippocampi seen in the autoradiog-
raphy but not in the VT. This is likely due to the hippocampus
definition within the mouse brain atlas being of much larger
volume when compared to the ROI drawn on the autoradiog-
raphy slices (see Supplementary Fig. 4).
To demonstrate the goodness of fit for the basis pursuit
denoising and parameter estimation, regional TACs have been
extracted from the original images and from images where
only the denoising/parameter estimation has been applied,
with no resolution recovery. The extracted TACs from 5 re-
gions for two representative animals (one baseline and one at
1-month post KA) are shown in Supplementary Fig. 6, along
with the residuals. The fits are visually quite good, and there is
no clear pattern in the residuals, showing the number of basis
functions used is appropriate. Because the fitting happens at a
voxel-wise level in this process, an average voxel-wise map of
the residuals are also shown in Supplementary Fig. 7 for each
time point, showing that on average the fits stay within 3% of
the curves.
The correlations between the parameters from the PETscans
and the autoradiography are shown in Fig. 4. For each time
point, and over all animals at all time points, there is an increase
in the correlation between the autoradiography and the PET
parameter with increasing iteration, which plateaus around 10
iterations. Looking at the %ID for 0 and 10 iterations of 4D-
RRD, the Pearson R increased by 35% by doing 4D-RRD only
(from 0.53 to 0.72). Correlations are further improved using the
VT value instead of the %ID with a total increase of 48% (from
0.53 to 0.79). The VT values without 4D-RRD (0 its) increased
the correlation over all time points by 24% compared to %ID
without 4D-RRD (from 0.66 to 0.79). The significance of the
Pearson R changes depending on the method applied, giving a
better indication of the strength of each method, as indicated as
significance levels in Fig. 4. The Pearson R coefficient is sig-
nificant for all methods used when including all time points at
once (7 regions at 4 time points = 28 correlation points).
Looking at the individual time points (7 regions = 7 correlation
points each), without 4D-RRD, the %ID original method only
gave significant PearsonR correlations at 7 days time point, and
the VT estimate without 4D-RRD was only significant at the 1-
month time point. Applying 4D-RRD generally produced sig-
nificant Pearson R coefficients, except for the Baseline group,
where only the 4D-RRD with 15 iterations had a significant
Pearson R.
As explained in the methods, the parameter estimate, VT
represents the VF + VNS + VS, whereas the autoradiography
represents the specific binding only. 18F-DPA714 being a
highly specific tracer, the non-specific binding should not be
a cause of discrepancy. This is shown by the blocking study
Fig. 2 aMean IDIF extracted from the presaturation studies, with fit and residuals underneath. bMean and standard deviation of extracted IDIFs, fitted
and metabolite corrected for the four time points with the peak inlaid
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carried out on the autoradiography slides where the non-
specific binding is negligible to non-existent (Supplementary
Fig. 5).
PET parametric maps: comparison
with autoradiography
Figure 5 shows the group averages for all mouse brain scans at
each time point for the %ID on original images (top), the VT
after 10 iterations of 4D-RRD (middle) and one representative
animal for each time point of autoradiography. Visually, the
lesion is much clearer at each time point in the VT maps
compared to the %ID and resembles the distribution of tracer
binding in the autoradiography images more closely. At
7 days, it is possible to make out sub-regions of the hippocam-
pus with higher binding in the VTmap. TheMRI overlaid with
the PET images at all time points (except for baseline, where
the atlas MRI was used) was the representative MRI obtained
at 6 months post KA induction to show the morphology
changes. This MRI image is also displayed without the PET
parametric map in Supplementary Fig. 2.
Discussion
The ability to extract an input function directly from the image
will be useful in small animal studies where it is extremely
challenging to do arterial sampling, and there is no true refer-
ence region available, such as in TSPO imaging. In this study,
we developed and assessed a robust and reproducible method
to extract the IDIF from dynamic mouse whole-body scans
using a FA approach. This mouse-specific IDIF is used for a
resolution recovery and denoising process that outputs an im-
age with better spatial resolution and less noise, as well as a
map of estimates of the VT. The VTestimated was compared at
a regional level to quantified 3H autoradiography across
groups of animals in a mouse model of epilepsy.
The 4D-RRD method used in this study was proposed by
Wimberley et al. [5] and Reilhac et al. [6] and uses an iterative
deconvolution combined with a basis pursuit denoising that
requires an input function or reference region TAC, neither of
which are possible for TSPO imaging in the mouse brain.
Extracting an IDIF using FA allows the use of this effective
method to improve quantitative accuracy. The visual improve-
ment obtained by using the 4D-RRD is evident in the
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parametric maps (Fig. 5), and the quantitative improvement is
shown in the correlations (Fig. 4) where the 4D-RRD process
improves the Pearson R between quantified autoradiography
and in vivo PET measurements from R = 0.53 in the original
%ID image to R = 0.79 in the VT map of 10 iterations.
Applying the basis pursuit method of voxel wise VT without
any resolution recovery (0 its) does improve the PearsonR (R =
0.66) compared to using %ID images without any resolution
recovery (R = 0.53). When looking at the individual time
points, the correlations improve when the pathology is the
strongest and thus yields larger regional differences, and the
methods used impact the significance of the Pearson correlation
coefficients.With 7 regions included in the correlation, the only
method that showed a significant correlation at all time points
was using the VT estimates from the 4D-RRD with 15 itera-
tions. Using 10 iterations of the 4D-RRD also produced signif-
icant correlations for all time points, except baseline, where
there is less regional variation. The improvement of the corre-
lations is echoed when looking at the confidence intervals of
each Pearson coefficient (Supplementary Table 1).
Separating the effect of the basis pursuit denoising and
parameter estimation from the resolution recovery and pre-
senting that alongside the combined techniques (4D-RRD)
demonstrate that using both elements gives more accurate
binding parameter estimates than just using one of the tech-
niques alone. This echoes the results shown in Reilhac et al.
[6] and Wimberley et al. [5] where the resolution recovery
greatly improved the accuracy of the parameter estimates
and the basis pursuit denoising reduced the variability.
FA has been previously used in medical image analysis
for different purposes, including the extraction of a blood
curve. In our application, the use of an injection pumpwith a
tracer injection time of 1 min made the blood curve very
reproducible, allowing for several physiological constraints
to guide FA. In previous applications [21, 24], the only
constraint applied was positivity, whereas in our applica-
tion, we also apply a similarity constraint to a curve extract-
ed from a presaturation experiment. In addition, the whole
mouse in the PET FOV is used, allowing more pools of
blood to be included in the analysis, which facilitates the
identification of the IDIF. Thirdly, the normalization proce-
dure is different from what has been previously described,
using the activity in the whole field of view to normalize the
factor curves. Lastly, this study estimated parameters of 18F-
DPA-714 binding to TSPO and compared them to quanti-
fied autoradiography measurements.
There have been methods of IDIF extraction proposed that
place a ROI within the aorta in order to extract a radioactivity
signal from the blood [10]; however, this measurement gives
the whole blood signal rather than the plasma. This is not ideal
for TSPO scans as the protein is present on red blood cells and
the signal from a ROI placed over a blood pool would be
contaminated with blood-bound TSPO [38]. The TAC would
also be contaminated by PVC effects of TSPO expression in
Pearson R correlations between autoradiography and PET values
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Fig. 4 Pearson R coefficients
between [3H]-DPA714
autoradiography and PET
measures for each time point post
kainic acid injection. The
coefficients between the
autoradiography and %ID or VT
are shown for original images and
after 4D-RRD processing. The
stars represent the significance
level of the Pearson R coefficient
(*p < 0.05, **p < 0.01,
***p < 0.001)
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the blood vessels and other nearby sources. One strong advan-
tage of using FA to extract an IDIF for TSPO tracers is that the
FA model accommodates mixed signal within voxels and can
estimate the contribution of each component (e.g. bound tracer
and free tracer) within voxels. To ensure that we were identi-
fying the right signals with FA, a set of presaturation experi-
ments was conducted, where all the TSPO in the mouse body
was blocked. In presaturation experiments, the whole blood
and plasma come into equilibrium very quickly, which is not
reached at all during tracer dose experiments due to TSPO
present within the blood [38]. Therefore, using the curve ex-
tracted from the presaturation experiments as a constraint for
the FA of tracer dose experiments, we can separate the signal
that comes from the specific binding within whole blood, and
the IDIF extracted would then be closer to the shape of the
plasma than the whole blood. Looking at Fig. 1, we have
identified curves that resemble specific binding and plasma
with respect to their spatial distribution as well as the curve
shape.
Quantification methods that propose the use of a
pseudo-reference region such as supervised clustering
analysis (SVCA) [39] have been tested in rat brain studies
but with varying success compared to application in the
human due to the limited number of voxels within the
rodent brain. The limited number of voxels is even more
of a problem for the mouse brain. SVCA has been tested
for use in the rat brain for 18F-DPA714 [40]; however, due
to high noise levels, it was modified to be used at a region
level as opposed to a voxel level, in effect identifying the
region with the lowest TSPO binding to be taken as the
pseudo-reference region. In pathologies where there are
many brain regions with elevated TSPO expression or
whole brain expression of TSPO, there will then be fewer
voxels or regions from the already limited number avail-
able for the algorithm to select. In this case, the algorithm
produces noisy or contaminated TACs to be a part of the
pseudo-reference curve. This has recently been shown by
one group [41] and would only be more present in the
mouse brain due to the smaller size of the brain, and fewer
voxels present. Additionally, the set-up of these methods
require the definition of the ideal reference curve which is
generally taken from the region with the lowest TSPO
binding in the healthy brain, which will still have TSPO
present. Extending beyond the brain to the whole body and
concentrating on blood allow for larger pools of voxels to
be included, and FA has the benefit of allowing voxels to
Fig. 5 Average parametric maps
for each time point post kainic
acid (baseline, 7 days, 1 month
and 6 months). The images are for
%ID (dark grey segment) and VT
(light grey segment) at a ventral
(top images) and dorsal (bottom
images) hippocampal slice. The
bottom segment (white) shows
the [3H]DPA-714 autoradiogra-
phy at the same time points for the
same slices for one representative
animal
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be made up of a mixture of the factors identified which are
related to underlying physiological signals.
The method presented in this article should be applicable
for other tracers. TSPO is a particularly challenging case
where a robust IDIF is very useful due to the ubiquitous nature
of the protein where it is present in healthy brain tissue and on
red blood cells. For quantification of TSPO scans, other com-
monly used methods are contaminated by the presence of the
target within the blood, heart, lung and vessel tissue or the low
level within the brain tissue.
One limitation of this study is the lack of arterial input func-
tion from the mice for validation purposes. We did not have
access to the usual gold standard of comparison for our extract-
ed IDIF (arterial blood sampling) due to the limited blood vol-
ume of the mouse. We instead used quantified autoradiography
as a comparison for our parameter estimates. There can be
differences between autoradiography and PET: in vivo vs
ex vivo morphology changes, resolution differences and differ-
ences in region definition, which can explain the difference
between autoradiography and VT as seen in the hippocampus.
Along with the morphology differences, discrepancies between
the autoradiography and the PET parameter estimates could be
related to the free tracer in the tissue, which could vary region-
ally, especially due to the disruption in the blood brain barrier
caused by the pathology. The non-specific binding present in
the PET parameter estimate could also play a role in any dis-
crepancies, but Supplementary Fig. 5 shows there is negligible
non-specific binding of 18F-DPA-714 in the mouse brain.
Additionally, not having access to the arterially sampled
input function means that there is no means to have an indi-
vidually sampled metabolite curve, so we used a population-
based metabolite curve. A metabolite curve experiment would
need to be repeated in an additional group of animals where
metabolic differences are expected such as due to systemic
disease state or pharmacological changes.
Conclusion
We presented a FA approach to IDIF extraction based on
whole-body mouse PET scans, and demonstrated that it is
robust and can be used in resolution recovery and noise re-
duction methods and parameter estimation for longitudinal
studies in the mouse when a reference region is not available.
This approach is especially useful for longitudinal whole-
body imaging studies in animals, where it is logistically or
practically difficult to do arterial blood sampling.
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